Chorionic gonadotropin β-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue

European Urology

Volumn 41, Issue 6, 2002, Pages 677-685

  Hotakainen, Kristina ^a   Haglund, Caj ^a   Paju, Annukka ^a   Nordling, Stig ^a   Alfthan, Henrik ^a   Rintala, Erkki ^a   Stenman, Ulf Håkan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bladder cancer; Chorionic gonadotropin; Immunohistochemistry

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; MESSENGER RNA;

ADULT; AGED; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; TISSUE DISTRIBUTION; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0036624716     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00125-2     Document Type: Article

References (45)

1. Engeland A. Haldorsen T, Tretli S, Hakulinen T, Horte LG, Luostarinen T, et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis: A collaborative study of the five Nordic Cancer Registries. APMIS Suppl 1995;49:1-161.
2. Whitmore Jr WF. Bladder cancer: Defining the clinical problem. Urology 1984;23:5-8.
3. Holmäng S, Hedelin H, Anderström C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995;153:1823-7.
4. Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D, Sidransky D. Molecular detection of primary bladder cancer by microsatellite analysis. Science 1996;271:659-62.
5. Miyanaga N, Akaza H, Ishikawa S, Ohtani M, Noguchi R, Kawai K, et al. Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur Urol 1997;31:163-8.
6. Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, et al. Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer. Urology 1998;51:44-50.
7. Braunstein GD, Vaitukaitis JL, Carbone PP, Ross GT. Ectopic production of human chorionic gonadotropin by neoplasms. Ann Intern Med 1973;78:39-45.
8. Alfthan H, Haglund C, Roberts P, Stenman UH. Elevation of free beta-subunit of human choriogonadotropin and core beta-fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res 1992;52:4628-33.
9. Dexeus F, Logothetis C, Hossan E, Samuels ML. Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies. J Urol 1986;136:403-7.
10. Iles RK, Jenkins BJ, Oliver RT, Blandy JP, Chard T. Beta-human chorionic gonadotropin in serum and urine. A marker for metastatic urothelial cancer. Br J Urol 1989:64:241-4.
11. Iles RK, Persad R, Trivedi M, Sharma KB, Dickinson A, Smith P, Chard T. Urinary concentration of human chorionic gonadotropin and its fragments as a prognostic marker in bladder cancer. Br J Urol 1996; 77:61-9.
12. Martin JE, Jenkins BJ, Zuk RJ, Oliver RT, Baithun SI. Human chorionic gonadotropin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder. Virchows Arch A Pathol Anat Histopathol 1989;414:273-7.
13. Moutzouris G, Yannopoulos D, Barbatis C, Zaharof A, Theodorou C. Is beta-human chorionic gonadotropin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy. Br J Urol 1993;72:907-9.
14. Oliver RT, Stephenson C, Collino CE, Parkinson MC. Clinicopathological significance of immunoreactive beta-hCG production by bladder cancer. Mol Biother 1988;1:43-5.
15. Campo E, Algaba F, Palacin A, Germa R, Sole-Balcells FJ, Cardesa A. Placental proteins in high-grade urothelial neoplasms. An immunohistochemical study of human chorionic gonadotropin, human placental lactogen, and pregnancy-specific beta-1-glycoprotein. Cancer 1989;63:2497-504.
16. Dirnhofer S, Koessler P, Ensinger C, Feichtinger H, Madersbacher S, Berger P. Production of trophoblastic hormones by transitional cell carcinoma of the bladder: Association to tumor stage and grade. Hum Pathol 1998;29:377-82.
17. Baltaci S, Kupeli S, Sak SD, Erden E, Sarica K. Human chorionic gonadotropin in serum and neoplastic tissue from patients with bladder carcinoma. Int Urol Nephrol 1995;27:289-95.
18. Marcillac I, Cottu P, Theodore C, Terrier-Lacombe MJ, Bellet D, Droz JP. Free hCG-beta subunit as turnout marker in urothelial cancer. Lancet 1993;341:1354-5.
19. Cook AM, Huddart RA, Jay G, Norman A, Deamaley DP, Horwich A. The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer. Br J Cancer 2000;82:1952-7.
20. Mora J, Gascon N, Tabernero JM, Rodriguez-Espinosa J, Gonzalez-Sastre F. Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients. Br J Cancer 1996;74:1081-4.
21. Hotakainen K, Lintula S, Stenman J, Rintala E, Lindell O, Stenman UH. Detection of messenger RNA for the beta-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reaction. Int J Cancer 1999;84:304-8.
22. Alfthan H, Haglund C, Dabek J, Stenman UH. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women. Clin Chem 1992;38:1981-7.
23. Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 1945;101:519-20.
24. Harmer M, editor. Union International Contre le Cancer (UICC): TNM Classification of Malignant Tumors. Geneva: WHO, 1978. p. 113-7.
25. Mostofi FK, Sobin LH. Torloni: Histological Typing of Urinary Bladder Tumors. International Classification of Tumors, Geneva: WHO, 1973.
26. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-48.
27. Alfthan H, Schroder J, Fraser R, Koskimies A, Halila H, Stenman UH. Choriogonadotropin and its beta-subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin Chem 1988;34:1758-62.
28. Louhimo J, Nordling S, Alfthan H, von Boguslawski K, Stenman UH, Haglund C. Specific staining of human chorionic gonadotropin beta in benign and malignant gastrointestinal tissues with monoclonal antibodies. Histopathology 2001;38:418-24.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
30. Ponte P, Ng SY, Engel J, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984;10:1687-96.
31. Iles RK, Butler SA. Human urothelial carcinomas - A typical disease of the aged: The clinical utility of human chorionic gonadotropin in patient management and future therapy. Exp Gerontol 1998;33:379-91.
32. Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, et al. Free human chorionic gonadotropin beta-subunit in gonadal and nongonadal neoplasms. Cancer Res 1992;52:3901-7.
33. Lazar V, Diez SG, Laurent A, Giovangrandi Y, Radvanyi F, Chopin D, et al. Expression of human chorionic gonadotropin beta-subunit genes in superficial and invasive bladder carcinomas. Cancer Res 1995;55:3735-8.
34. McLoughlin J, Pepera T, Bridger J, Williams G. Serum and urinary levels of beta-human chorionic gonadotropin in patients with transitional cell carcinoma. Br J Cancer 1991;63:822-4.
35. Jenkins BJ, Martin JE, Balthun SI, Zuk RJ, Oliver RT, Blandy JP. Prediction of response to radiotherapy in invasive bladder cancer. Br J Urol 1990;65:345-8.
36. Ozkardes H, Ergen A, Ozen HA, Ayhan A, Remzi D. Immunohistochemical detection of beta-human chorionic gonadotropin in urothelial carcinoma. Int Urol Nephrol 1991;23:5-11.
37. Bacchi CE, Coelho KI, Goldberg J. Expression of beta-human chorionic gonadotropin (beta-hCG) in non-trophoblastic elements of transitional cell carcinoma of the bladder: Possible relationship with the prognosis. Rev Paul Med 1993;111:412-6.
38. Smith DJ, Evans HJ, Newman J, Chapple CR. Ectopic human chorionic gonadotropin (HCG) production: Is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder. Br J Urol 1994;73:409-12.
39. Iles RK, Purkis PE, Whitehead PC, Oliver RT, Leigh I, Chard T. Expression of beta-human chorionic gonadotropin by non-trophoblastic non-endocrine 'normal' and malignant epithelial cells. Br J Cancer 1990;61:663-6.
40. Murphy WM, Soloway MS, Jukkola AF, Crabtree WN, Ford KS. Urinary cytology and bladder cancer: The cellular features of transitional cell neoplasms. Cancer 1984;53:1555-65.
41. Sharma S, Zippe CD, Pandrangi L, Nelson D, Agarwal A. Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat. J Urol 1999;162:53-7.
42. Stenman J, Finne P, Stahls A, Grenman R, Stenman UH, Palotie A, Orpana A. Accurate determination of relative messenger RNA levels by RT-PCR. Nat Biotechnol 1999;17:720-2.
43. Bellet D, Lazar V, Bieche I, Paradis V, Giovangrandi Y, Paterlini P, et al. Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cells. Cancer Res 1997;57:516-23.
44. Gillott DJ, Iles RK, Chard T. The effects of beta-human chorionic gonadotropin on the in vitro growth of bladder cancer cell lines. Br J Cancer 1996;73:323-6.
45. Butler SA, Ikram MS, Mathieu S, Iles RK. The increase in bladder carcinoma cell population induced by the free beta-subunit of human chorionic gonadotropin is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer 2000;82:1553-6.